Assessment of the biological and pharmacological effects of the alpha nu beta3 and alpha nu beta5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/17693653

Download in:

View as

General Info

PMID
17693653